KR20200118627A - Inhibition of melanin synthesis using adult stem cells culture media - Google Patents

Inhibition of melanin synthesis using adult stem cells culture media Download PDF

Info

Publication number
KR20200118627A
KR20200118627A KR1020190040779A KR20190040779A KR20200118627A KR 20200118627 A KR20200118627 A KR 20200118627A KR 1020190040779 A KR1020190040779 A KR 1020190040779A KR 20190040779 A KR20190040779 A KR 20190040779A KR 20200118627 A KR20200118627 A KR 20200118627A
Authority
KR
South Korea
Prior art keywords
stem cells
cells
stem cell
melanin
whitening
Prior art date
Application number
KR1020190040779A
Other languages
Korean (ko)
Inventor
고세용
Original Assignee
주식회사 오앤영인터내셔날
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 오앤영인터내셔날 filed Critical 주식회사 오앤영인터내셔날
Priority to KR1020190040779A priority Critical patent/KR20200118627A/en
Publication of KR20200118627A publication Critical patent/KR20200118627A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Abstract

The present invention relates to a human mesenchymal stem cell and a novel use of a stem cell culture medium and, more specifically, to a mesenchymal stem cell extracted from human fat, placenta, cord blood, or bone marrow; a stem cell culture medium obtained by culturing the same in an appropriate medium and under an appropriate condition, resulting in the activity of inhibiting melanin synthesis; or a method for using the same as a raw material for whitening-related drugs, quasi-drugs and cosmetics.

Description

줄기세포 배양액을 이용한 멜라닌 합성저해 방법{Inhibition of melanin synthesis using adult stem cells culture media}Inhibition of melanin synthesis using adult stem cells culture media

본 발명은 인간의 중간엽 줄기세포 및 줄기세포 배양액의 새로운 용도에 관한 것이다.This  invention is  about human   mesenchymal   stem cells   and   stem cells   new   uses of culture fluid.

보다 상세하게는, 인간의 지방, 태반, 제대혈 또는 골수에서 추출된 중간엽 줄기세포 또는 이를 적정한 배지In more detail,  human   fat,   placenta,   cord blood   or   extracted from bone marrow   mesenchymal   stem cells   or   tooth   appropriate   medium

및 조건에서 배양한 줄기세포 배양액은 멜라닌 합성을 저해하는 활성을 가지므로 이를 미백과 관련된 의약품,And     cultured   stem cells   cultured   melanin   inhibits the synthesis   has the activity     teeth   whitening   related   drugs,

의약부외품, 화장품의 원료로 이용하는 방법에 관한 것이다.It is about quasi-drug and  cosmetics  how to use  as raw materials.

사람의 피부색을 결정하는 멜라닌(melanin)은 멜라노사이트(melanocyte)라 불리는 피부 세포에서 만들어져 케라Melanin, which determines the color of human skin, is called melanocytes, called melanocytes, and is made from cells.

티노사이트(keratinocyte)라는 표피 세포로 이동한다. 여기서 멜라닌은 핵주변에 모자와 같은 구조를 형성하여It moves to  epidermis  cells called keratinocytes. Here,  melanine   forms a   structure like a hat and   around the nucleus,

자외선으로부터 유전자를 보호하고 자유 래디컬(free radical)을 제거하여 세포 내 단백질을 보호하는 등 중요Protects  genes   from ultraviolet   free   removes free   radicals   protects cells   in   proteins  

한 역할을 하게 된다. 이러한 멜라닌을 분해하는 효소가 생체 내에는 없고 다만 케라티노사이트가 표피에서 떨It becomes one-of-a-kind. These  melanin-degrading  enzymes  in the body   , but  but keratinocytes  in the epidermis

어져나갈 때 같이 피부에서 떨어져나가는 것으로 제거된다. 하지만, 멜라닌이 필요이상으로 많이 생기게 되면When it grows, it is removed from the skin as it is  . However, if  melanine  more   than necessary  

기미나 주근깨, 점 등과 같이 과색소침착증을 유발하여 미용상으로 좋지않은 결과를 가져오게 된다. 또한, 레져It causes   and pigmentation   like spots   freckles,   spots  , etc.   brings   unfavorable results   cosmetically. Also,  Leisure

인구의 증가로 외부에서 활동하는 것을 즐기는 사람들이 많아지면서 자외선에 의한 멜라닌 색소 침착을 막고자With the increase of the population   being active   enjoying     increasing     by ultraviolet rays   melanin   pigmentation   to prevent  

하는 요구가 증가하게 되었다. 이에 과도한 멜라닌 생성을 막는 미백제 개발이 필요하게 되었고 그 동안 많은  demand to do   increased  . Therefore,  to prevent excessive   melanin   production   whitening agent   development   necessary  

노력들이 이루어졌다.Efforts have been made.

이제까지의 미백제 개발은 주로 멜라닌 생합성에서 없어서는 안될 기본적이면서도 가장 중요한 역할을 하는 효So far, the development of  whitening agents  mainly   melanin   in biosynthesis   should not be   basic yet   most   important   role   effect

소인 티로시나아제(Tyrosinase)의 활성을 저해하는 것을 통해 멜라닌 양을 줄이는 물질을 찾는 것으로 이루어It consists of   to reduce the amount of melanin   through the   activity of tyrosinase   inhibit       find a substance  

져왔다. 이렇게 개발된 미백제로 코지산, 알부틴, 글루타치온, 비타민 A, 비타민 C 등이 있지만 소비자들이 만Brought. There are  developed   whitening agents  kojic acid,   arbutin,   glutathione,   vitamins   A,   vitamins   C , but   consumers only  

족할 만한 미백효과를 갖지 못하고 있으며 부작용 때문에 그 사용량에 제한적인 문제점이 있다. 따라서 이제까It does not have satisfactory     whitening effect   and   due to side effects     it   usage   limited   problem  . So  

지의 미백제보다 효능이 뛰어나고 좀 더 안전한 미백제를 개발하는 것이 절실한 실정이다.  is more effective   than lichen   whitener   a little   more   safe   whitening agent   development   urgent   actual situation.

이에, 본 발명자들은 우수한 미백효과를 나타내면서도 부작용이 없는 새로운 미백제를 제공하기 위하여 노력한Accordingly, the  this  inventors  provided  excellent   whitening effect   while   has no side effects     new  providing   to provide  

결과, 줄기세포 배양액이 부작용없이 멜라닌 생성을 효과적으로 억제할 수 있음을 발견하고 본 발명을 완성하As a result,   found that   stem cells   cultured   can effectively   inhibit   production   without side effects     found   seen   invention   completed

였다.Was.

본 발명은 중간엽 줄기세포로부터 수득한 배양액 또는 그 배양액으로부터 분리된 단백질을 이용한 안전하고 효This  invention is  mesenchymal   obtained from stem cells   culture solution   or   group   separated   protein   using   safe and effective

과적인 미백관련 의약품 또는 화장품을 제공하는 것을 목적으로 한다.Overloaded   whitening-related   drugs   or   to provide   cosmetics   purpose  .

본 발명은 줄기세포 배양액 또는 그 배양액에서 분리된 단백질을 포함하는 미백용 화장료 조성물을 제공한다.This  invention provides   for   for whitening   cosmetics   composition containing   separated   protein   from   stem cells   culture solution   or   group   culture solution.

이 때 상기 줄기세포는 포유동물에서 유래된 성체줄기세포 및 중간엽 줄기세포를 포함한다. 또한 상기 성체줄기At this time, the above   stem cells include  adult stem cells   and   mesenchymal stem cells   derived from mammals. Also   above   adult stem

세포는 지방조직, 골수조직, 제대혈 또는 태반에서 분리된 줄기세포를 포함한다.Cells include   adipose tissue,   bone marrow tissue,   umbilical cord blood   or   stem cells   isolated from the placenta.

줄기세포란 미분화 세포로서, 오랜기간 동안 분열을 하고 자기 갱신(self-renewal)을 할 수 있으며, 어떤 조건Stem cells are   undifferentiated   cells,   for a long time     dividing     self-renewal     able  ,   some conditions

이 주어지면 다양한 종류의 세포로 분화할 수 있는 세포를 말한다. 줄기세포는 기원되는 조직에 따라 배아줄기Given this  , it refers to the  various   kinds of   cells   which can be divided into       cells. Stem cells are  in accordance with the origin   tissue   embryonic stem

세포와 성체줄기세포로 나뉘어 지게 되는데, 잠재 능력은 배아줄기세포보다 한정적인 단점이 있으나 윤리적 문It is divided into cells and   adult stem cells  , and   potential   ability   than embryonic stem cells   limited   disadvantages   but   ethical   question

제가 없고 부작용이 없는 성체줄기세포를 대상으로 많은 치료제가 연구되고 있다.I have no   and no side effects     targeting adult stem cells   many   treatments   have been studied  .

구체적으로, 본 발명에서는 성인의 지방세포로부터 분리한 성체줄기세포를 이용하고 이는 지방조직 내에 존재하Specifically, in the  this invention,  uses   isolated   adult stem cells   from   adipocytes of an adult   and   exists in   adipose tissue  

는 세포 중 간단한 정제과정을 거쳐서 획득이 가능하다. 지방조직의 획득에 대한 과정은 통상적으로 흔히 시행It is possible to obtain   cells   out of   through a simple   purification process  . The   process for the acquisition of local tissues   is usually   often implemented  

되는 지방흡입의 과정에서 폐기되었던 지방조직을 이용하는 것으로, 추가적인 침습적 시술이 필요 없기 때문에Because   in the   process of liposuction   that was   adipose tissue   used  ,   additional   invasive   procedure   required   not  

그 유용성이 배가된다.Its  useability   doubles.

인간의 지방 조직을 국소마취 하에서 지방흡입으로 수득하고 지방조직의 세포외기질(extracellular matrix)을Human   fat   tissue   under local anesthesia     by liposuction   and   extracellular   matrix of adipose tissue

콜라게나아제로 효소처리한 후 원심 분리하고 단핵세포, 적혈구 및 여러 가지 세포파편을 분리하여 줄기세포를After   enzymatic treatment with collagenase  ,   centrifuged   separated   mononuclear cells,   erythrocytes   and   several   branches   cell debris   separated   stem cells

얻는다.Get

통상적으로 흔히 병의원에서 시행되는 지방흡입의 과정에서 얻어져 폐기되던 지방조직을 무균 상태로 수집하면Normally  commonly  in the   practiced   in the   process of liposuction   obtained   discarded   adipose tissue   aseptic  

얻을 수 있고, 분리한 지방 흡입물에서 순수한 지방조직만을 분리한다.Separate only   pure   adipose tissue   from the obtained     and   separated   fat   inhalation.

분리된 줄기세포는 혈청을 포함하는 Dulbecco's Modified Eagle's Medium(DMEM)의 비유도성 배지에 배양하여Separated   stem cells     containing serum   Dulbecco's   Modified   Eagle's   Medium (DMEM)   in non-inducible   cultured in medium

비접착성 세포들을 제거한다.Remove non-adhesive   cells  .

상기 과정으로 단리한 줄기세포를 3계대로 배양하고, 원심분리하여 상등액을 여과함으로써 본 발명에 따른 지방    isolated   stem cells   in the above   process       by centrifuging   and filtering the supernatant     fat according to the invention  

유래 줄기세포 배양액을 수득한다.Derived   stem cells   culture solution was obtained.

지방세포로부터 성체줄기세포를 단리하고 배양하는 과정은 본 발명의 방법에 한정되지 않고 당업계에서 통상적The process of  isolating   adult stem cells   from adipocytes     is not limited to the   original   invention   method  

으로 수행되는 방법으로 실시가능하다.It is possible to implement it by the method that is performed by the method.

본 발명에 따른 지방유래 줄기세포 배양액에 존재하는 미백활성 관련 단백질을 확인하기 위하여, LC-MS/MS를 실 According to the present  invention  Adipose-derived   Stem cells  Existing in the culture solution  Whitening activity   Related  To check the protein  ,  LC-MS/MS

시하였다.Timed.

그 결과 지방유래 줄기세포 배양액에는 티로시나아제, TRP1 및 TRP 2를 억제하고 Mitf(microphthalmia-The result  Adipose-derived  Stem cells  In the culture solution,  Tyrosinase,  TRP1  and  TRP 2 were  inhibited  Mitf (microphthalmia-

associated transcription factor)를 downregulation하거나, 멜라노좀을 전이하는데 관여하는 단백질이 다수associated  transcription  factor)  downregulation, or  melanosomes  transferring   involved   protein  

함유되어 있음을 확인하였다(표 1 참조).It was confirmed that it contained   (refer to Table   1 ).

따라서 본 발명에 따른 지방유래 줄기세포 배양액은 피부의 색소침착을 예방하거나 치료하는 미백용 화장품에Therefore,  this  invention   derived from fat   stem cells   cultured   prevents   pigmentation of the skin   or treats   whitening   cosmetics

유용하게 사용될 수 있다.It is useful   can be used  .

또한 본 발명에서는 본 발명에 따른 지방유래 줄기세포 배양액이 멜라닌 생성을 억제하고 티로시나아제 활성을 저해하는 지 확인하기 위하여,멜라노마 세포주에 멜라닌 자극 호르몬과 본 발명에 따른 지방유래 줄기세포 배양액을 처리한 다음 생성된 멜라닌과 티로시나아제 활성을 측정하였다.In addition, in the present invention, processing the adipose derived stem cell culture according to the adipose derived stem cell culture according to the invention inhibit the melanin synthesis and tyrosinase in order to ensure that inhibits the activity, and melanin-stimulating hormone on melanoma cell lines, the present invention One   next   produced   melanin and tyrosinase   activity was measured.

그 결과, 본 발명에 따른 지방유래 줄기세포 배양액이 멜라닌의 생성을 억제하고 티로시나아제 활성을 억제하는As a result,  This  According to the invention  Adipose-derived   Stem cells  The culture fluid  Inhibits the  production of melanin  and  Tyrosinase  Inhibits the activity

것을 확인하였다I confirmed that

또한, 본 발명에 따른 지방유래 줄기세포 배양액을 줄기세포와 함께 인체 피부에 투여한 결과 현저한 피부흑화In addition,   followed by the invention   fat-derived   stem cells   culture fluid   with stem cells   administered   to the human body   skin   result   remarkable   skin darkening

개선 효과를 보였다.It showed improvement   effect  .

따라서 본 발명에 따른 지방유래 줄기세포 및 그 배양액은 피부의 색소 침착을 예방하거나 치료하는 미백용 화Therefore,  this  invention   fat-derived   stem cells   and   group   culture fluid   to prevent   pigmentation   sedimentation   or treat   whitening  

장품에 유용하게 사용될 수 있다.There are   useful     number   in equipment.

본 발명에 따르면 중간엽 성체줄기세포를 이용하여 인간의 성장인자를 포함한 배양액을 생산하여 멜라닌 합성According to the present invention,   using mesenchymal   adult stem cells   using   human   growth factor   containing   culture solution   production   melanin   synthesis

저해 및 티로시나아제 활성을 억제하는 것을 확인하였다. 따라서 지방유래 줄기세포의 배양액 및 그로부터 분Inhibition   and   tyrosinase   activity was confirmed   inhibiting  . Therefore,  Adipose-derived     culture fluid   and   minutes from it

리한 단백질을 미백용도의 의약품, 의약부외품, 화장품 등에 적용하여 유용하게 사용할 수 있을 것으로 기대된다.It is expected that   will be useful   used   can be used   by applying rihan  protein to   drugs for whitening purposes,   quasi-drugs, cosmetics, etc.

본 발명을 실시예에 의거하여 더욱 상세히 설명하면 다음과 같으며, 본 발명의 범위는 다음 실시예에 의해 한정This  invention  based on       more   in detail   is as follows  ,   the scope of this   invention is   following     limited by  

되는 것은 아니다.It is not  .

<실시예 1> 지방줄기세포의 단리 및 배양<Example  1>  Isolation   and   culture of adipose stem cells

인간의 지방흡입물 10㎖ (리더스피부과, 서울)을 동일 부피의 인산화 완충 용액으로 세척하고 지방조직만을 분Human   liposuction   10 ㎖   (Leader's Dermatology,   Seoul)   same   volume of   phosphorylation   buffer   solution   washing   only adipose tissue   minutes

리하였다.I did it.

지방조직의 세포외기질을 37 ℃?, 5 % CO2 배양기에서 45 분간 0.075 % 콜라게나아제로 효소처리하고, 최적의 효  extracellular matrix of adipose tissue  37 ℃?,  5 % CO2 in the incubator  45 min  0.075 %  collagenase   enzyme treatment,   optimal effect

소 처리된 지방조직을 1200 g에서 5분간 원심분리하여 고밀도의 줄기세포를 포함한 스트로마성 혈관 분획을 수Bovine   treated   adipose tissue   1200   g   5 minutes   centrifugation   high density   stem cells   containing   stroma   blood vessels   fraction

득하였다. 펠렛을 인산화 완충 용액으로 세척하고 70㎛ 나일론 세포 여과기를 통하여 기타 조직을 제거하고I got it. Wash the pellet with  phosphorylation   buffer   solution   70㎛   nylon   cells   filter   remove   other   tissues

Histopaque-1077(SIGMA)로 적혈구를 포함한 세포파편과 단핵세포만을 분리하였다.Histopaque-1077 (SIGMA) was used to separate  cell fragments containing erythrocytes and mononuclear cells only.

분리된 단핵세포를 Dulbecco's  Modified  Eagle's  Medium(DMEM),  10  %  fetal bovine serum(FBS), 1 %Isolated  Monocytes  Dulbecco's Modified Eagle's Medium(DMEM), 10 % fetal bovine serum(FBS), 1 %

penicillin streptomycin이 포함된 배양액으로 37 ℃?, 5 % CO2, 배양기에서 24 시간 배양 후 비접착성 세포들을 제거함으로써 줄기세포를 10 개 단리하였다.Stem cells were opened by removing  37 ℃,  5 % CO2,  24 hours   culture   after   non-adhesive isolation   cells with   culture solution containing penicillin   streptomycin  .

단리한 줄기세포가 10 cells/㎖가 되도록 세포 부유액 10 ㎖를 T25 플라스크(면적 25 ㎠, 용량 50 ㎖)에 옮겨Transfer the isolated   stem cells  10 cells/ml  cells suspended fluid  10 ㎖ into  T25  flask (area  25 ㎠,   capacity  50 ㎖)

상기 조건에서 배양하였다.It was cultured in the above conditions.

누적집단배증시간 (doubling time)은 플라스크 내 배양중인 세포가 80 % 합류(confluence) 때까지 유지하고 80The cumulative group doubling time   is kept   in the flask       cells being cultured  80 %  until confluence   80

% 합류시기에 계대배양을 수행하였다.%   Passage culture was performed at the time of consolidation.

계대배양은 배양액을 제거한 플라스크를 PBS로 세척하고 0.25 % Trypsin-EDTA(GIBCO)로 세포를 떨어뜨린 후 세For subculture,  Remove the culture solution  Wash the flask  PBS  , and  0.25  %   Trypsin-EDTA (GIBCO)  After dropping the cells  

포부유액을 원심분리 후, 세포수 측정과 viability 검사한 뒤 DMEM, 10 % FBS, 1 % penicillin streptomycin이After   centrifugation  ,   cell count   and   viability   test   after   DMEM,  10 % FBS,  1 % penicillin streptomycin

포함된 배양액에서 다시 3 배로 계대배양 하였다. 상기 과정을 3 번 반복하였다.From the included   culture solution, it was   again   3   times   passage culture  . The   process was repeated  3  times  .

<실시예 2> 줄기세포 배양액 생산<실시예 1>에서 단리, 계대배양된 지방유래 줄기세포 4Х 10 개를 무혈청 배지인 DMEM/F12(Invitrogen-Gibco-<Example   2>   stem cells   culture solution   production   isolated,   subcultured   fat-derived   stem cells   4   10   dogs   serum-free   medium  DMEM/F12 (Invitrogen-Gibco

BRL, Grand Island, NY)를 이용하여 72 시간 배양한 후, 배양액을 300 g, 5 분간 원심분리 하여 상등액을 0.22BRL,  Grand Island,  NY)  72 hour after    ,  300 g,  5 min  centrifugation   supernatant  0.22

㎛ 주사식 여과기로 여과하여 지방줄기세포 배양액을 준비하였다.      adipose stem cells   culture solution was prepared by filtration with a ㎛   injection type   filter.

<실시예 3> 지방줄기세포 배양액의 단백질 분석<Example  3>  Adipose stem cells     Protein   analysis of culture solution

3-1. 단백질의 트립신 분해 3-1. Trypsin digestion of proteins

<실시예 2>에서 준비된 지방줄기세포 배양액을 동결건조기를 이용하여 동결건조 하였다. 건조된 분말을 멸균된The   fat stem cells   culture solution prepared in <Example   2> was   freeze-dried using   freeze dryer  . Dried   powder   sterilized

증류수에 용해시킨 후 고체상 추출 카트리지(Waters, USA)를 이용하여 단백질을 회수하였다. 단백질을 C18 역상After   dissolved in distilled water   solid phase   extraction   using a cartridge (Waters, USA)   protein was recovered. Protein  C18 reverse phase

크로마토그래피 (Chromolith , Merck)를 이용하여 6 개의 군으로 분획하였다. 각 분획을 환원완충액(50 mMChromatography   (Chromolith  ,   Merck) was used to divide   into 6   groups. Each   fraction  reduction buffer (50 mM

NH4HCO3, 2 mM DTT)을 이용하여 20 분간 56 ℃에서 환원시켰다. 환원된 단백질을 알킬화 완충액(50 mM NH4HCO3,NH4HCO3,  2 mM DTT) was used to reduce   at  20  minutes at  56 ℃. Reduced   protein   alkylation   buffer solution (50 mM NH4HCO3,

5 mM iodoacetamide)으로 37 ℃에서 15 분간 알킬화 한 후, 트립신으로 37 ℃에서 12 시간 분해하였다.5 mM iodoacetamide) was decomposed at  37 ℃ for  15  minutes   alkylation   limited  , and   trypsin at  37 ℃  12  hours  .

3-2. Q-TOF를 이용한 LC-MS/MS 분석 3-2. LC-MS/MS analysis using Q-TOF

트립신으로 분해한 각 군의 펩티드 분획을 Agilent 1100 LC system(Agilent, USA)을 Q-STAR Excel massTrypsin   decomposed   each   group   peptide   fraction   Agilent   1100   LC   system (Agilent,   USA)  Q-STAR Excel mass

spectrometer(MDS Sciex, Toronto, Canada)와 연결하여 분리 분석 하였다. 결과는 Analyst QS software의  was connected with a spectrometer (MDS Sciex, Toronto, Canada) and  separated   analyzed . The result is  Analyst QS software

information-dependent acquisition mode를 이용하여 획득하였다.Acquisition was obtained by using the information-dependent acquisition mode.

다가이온은 MS/MS를 이용하여 선별하였다. 각 cycle은 1-s MS와, 3-s MS/MS로 구성하였고, acetonitrile의Polyion was selected using  MS/MS  . Each  cycle was composed of  1-s MS and  3-s MS/MS, and  acetonitrile

12.5 %~40 %의 농도구배로 linear LC를 이용하여 90 분간 처리하였다.Using a  linear  LC of 12.5 %~40 %   for  90  minutes.

각 전구이온은 tandem MS로 선택한 후 LC-MS/MS를 이용하여 분석하였다.Each   bulb ion was analyzed   using  tandem  MS   selected   after   using LC-MS/MS.

LC-MS/MS를 3회 분석하여 각 군의 펩티드 분획을 결정하였다.LC-MS/MS was analyzed 3 times to determine the  peptide   fraction of each   group.

3-3. Database 검색 LC-MS/MS결과를 MASCOT 검색엔진(Matrix Science, London, United Kingdom) 을 이용하여 human International3-3. Database search LC-MS/MS results are converted to human International by using MASCOT search engine (Matrix Science, London, United Kingdom).

Protein Index(IPI) 단백질 서열 database에서 검색을 하였다. MS의 정확도는 1200 ppm이고, MS/MS 정확도는Protein   Index (IPI)   protein   sequence   in the database   search was performed. MS's  accuracy is  1200 ppm, and  MS/MS accuracy is

0.3 Da이며, 트립신 분해 오차 및 O-deoxy-carbamidomethylated 시스테인, 산화 메티오닌의 다양한 변형, N-말0.3 Da,  trypsin   decomposition   error   and   O-deoxy-carbamidomethylated   cysteine,   oxidation   of methionine   various   modifications,   N-horse

단 아세틸화 단백질수준에서 검색하였다.We searched for   at the level of acetylated   protein.

database 검색결과 총 112개의 단백질을 동정하였고, 미백에 관련된 단백질을 선별하여 작성하였다.Results of database   search   total   112   proteins were identified, and   related   related to whitening   was selected and   was written.

살펴본 바와 같이,지방세포 유래 줄기세포 배양액에는 티로시나아제,TRP1 및 TRP 2를 억제하고 Mitf(microphthalmia-associated transcription factor)를 downregulation하거나, 멜라노좀을 전이하는데 관여As shown, in the adipocyte-derived stem cell culture medium, it inhibits tyrosinase, TRP1 and TRP 2, and  downregulates Mitf (microphthalmia-associated  transcription  factor), or  involves   metastasis of melanosomes.

하는 단백질이 다수 함유되어 있음을 알 수 있다.It is known that   contains   many          .

<실시예 4> B16 세포주의 멜라닌 억제실험<Example   4>  B16   Cell line   Melanin   Inhibition experiment

설치류 멜라노마 세포주인 B16 세포주를 DMEM 배지에 10 % 우태혈청과 100 U/㎖ 페니실린, 100 ㎍/㎖Rodent   Melanoma   Cell line   B16   Cell line   DMEM   In medium  10 %  Fetal calf serum  100  U/ml  Penicillin,  100 ㎍/㎖

streptomycin을 첨가하여 37 ℃?, 5 % CO2, 조건에서 배양하였다.Streptomycin was added and cultured under the conditions of  37 ℃?,  5 % CO2, .

33

배양된 B16 세포를 96-well 플레이트에 well 당 2ⅹ10 개의 세포를 접종하고, 멜라닌자극호르몬인 α-MSH 각각Cultured  B16   cells  96-well   plates   2   per well     2     cells  , and   melanin-stimulating hormone  α-MSH  respectively

100 nM 과 지방줄기세포 배양액 0 %, 10 %, 50 %, 100 %이 포함된 시료액 200㎕ 를 동시에 처리하였다. 72 시100 nM  and  fat stem cells   culture solution  0 %,  10 %,  50 %,  100 %   sample solution  200 µl   was treated at the same time. 72  hours

간 후에 CCK-8(Dojindo, Gaithersburg, MD) 용액 10ul을 각 well에 첨가 한 후 3 시간 동안 배양하여,microplate reader(TECAN, Grodig, Austria)로 450㎚에서 흡광도를 측정하였다. 측정된 값은 표준곡선을 작성하여 보정하였다.After liver  ,  CCK-8(Dojindo, Gaithersburg, MD) solution 10ul was added to each  well   and after  3   time     was cultured and measured with microplate   reader (TECAN,    , 450 nm). The measured   value was corrected by making   standard curve  .

다음으로, 배양된 B16 세포를 plate에 1.5ⅹ10  개씩 접종한 후 실시예 2에서 수득한 지방줄기세포 배양액 10Next,   cultured   B16   cells in   plate  1.5ⅹ10 Dogs   After inoculation     In Example   2   Obtained   Fat stem cells   Culture solution   10

㎖을 각각 0 %, 10 %, 50 %, 100 % 씩 한 시간 동안 전 처리하고, α-MSH 100 nM 을 72시간 처리 후에 인산화  each   0 %,  10 %,  50 %,  100 %  each   for one hour     before  ,  α-MSH  100 nM  after phosphorylation   72 hours  

완충용액으로 배지를 씻어준 후 멜라닌 추출용액(1N NaOH+50 % DMSO)을 well당 100 ㎕씩 첨가하여 80 ℃에서 세After washing the medium with a buffer solution, add melanin extract (1NNaOH + 50% DMSO) per well, and wash it at 80°C by adding 100µl at a rate of   per well  

포를 용해시킨 후 마이크로플레이트 리더기로 492㎚에서 멜라닌의 흡광도를 측정하였다(도 3 참조).After dissolving the fabric, the absorbance of melanin was measured at 492 nm with a microplate reader (refer to Fig. 3).

그 결과 지방유래 줄기세포 배양액 50 % 또는 100 %를 α-MSH와 함께 처리한 군은 지방유래 줄기세포 배양액을The result   fat-derived   stem cells   culture solution   50  %   or   100  % treated with   α-MSH     group   fat-derived   stem cells  

처리하지 않은 군에 비하여 현저한 멜라닌 생성 억제 효과를 보였다.Compared to the untreated   group   showed remarkable   melanin   production   inhibition   effect.

<실시예 5> 티로시나아제 억제실험<Example  5>  Tyrosinase   inhibition experiment

5-1 티로시나아제 활성실험 5-1 Tyrosinase activity test

시험관에 0.1 M 인산염완충액(pH 6.5) 220㎕와 B16 세포에서 추출한 티로시나아제 20㎕ 그리고 버섯 티로시나아In a test tube  0.1 M phosphate buffer (pH 6.5) 220   and   extracted   from B16   cells   tyrosinase   20   and   mushroom   tyrosinaa

제 20㎕를 순서대로 넣었다. 이 용액에 1.5 mM 티로신 액 40 ㎕를 넣고 37 ℃에서 10~15분 동안 반응시키고,The first 20 µl was put in the order of  . Add  1.5 mM Tyrosine solution 40 µl to this solution and let it react at  37 ℃ for 10-15 minutes ,

이를 마이크로플레이트 리더기를 이용하여 490㎚에서 흡광도를 측정하였다.The absorbance was measured at 490 nm using a microplate reader.

상기 실시예 4의 시료액을 각각 200㎕ 으로 티로신 액을 처리하기 전 에 처리하였고, 공시료액으로는 시료액 대신 0.1 M 인산염완충액(pH 6.5)을 넣었다.The   sample solution of Example 4 was   each  200 µl     tyrosine     treated   before    ,   sample solution was   sample solution   instead of   0.1     phosphate buffer was added.

그 결과 도 1에서 나타난 바와 같이, 그 결과 지방유래 줄기세포 배양액 50 % 또는 100 %를 α-MSH와 함께 처리 Results   also   appearing in 1   bara  ,   results   fat-derived   stem cells   culture fluid   50  %   or   100  % treated with  α-MSH  

한 군은 지방유래 줄기세포 배양액을 처리하지 않은 군에 비하여 현저한 티로시나아제 활성 저해 효과를Compared to the   fat-derived   stem cells   culture solution   untreated     remarkable   tyrosinase   activity   inhibitory   effect

보였다.Showed.

5-2 티로시나아제 억제실험 5-2 Tyrosinase inhibition experiment

시험관에 0.1 M 인산염완충액(pH 7.0) 850 ㎕와 상기 실시예 4의 시료액 50 ㎕ 그리고 버섯 티로시나아제 50㎕를 순서대로 넣고 37℃에서 6분동안 반응시켰다.In a test tube,  0.1 M phosphate buffer (pH 7.0) 850 ul and  above   Example  4   sample solution  50    and mushroom   tyrosinase  50 µl were sequentially added and reacted at 37°C for 6 minutes.

이 용액에 0.06 mM L-DOPA(L-3,4-dihydroxyphenylalanine)용액 50 ㎕를 넣은 다음 37 ℃에서 1 분 동안 반응시킨다. 공시료액으로는 0.1 M 인산Add 0.06 mM L-DOPA (L-3,4-dihydroxyphenylalanine) solution  50    to this solution   and then react at 37  ℃ for 1   minute  . 0.1 M phosphoric acid

염완충액(pH7.0)을 넣었다.A salt buffer solution (pH 7.0) was added.

<실시예 6> 티로시나아제의 Western blot 분석<Example  6>  Western  blot   analysis of tyrosinase

배양된 B16 세포를 plate에 1.5ⅹ10 개씩 접종한 후 지방줄기세포 배양액 10㎖ 을 각각 0 %, 10 %, 50 %, 100Cultured  B16  cells  1.5ⅹ10  each in  plate  After  Adipose stem cells   Culture solution  10㎖   Each  0 %,  10 %,  50%,  50 %

% 씩 두 시간 동안 전 처리 후, 실시예 4의 시료액을 10㎖ 처리하였다.After each%   two   hours   before   treatment  , the   sample solution of Example 4 was treated with 10 ml_

48 시간 후에 세포를 RIPA 완충용액(50 mM Tris-HCl, 0.15 M NaCl, 1 mM EDTA, 1 % Triton X-100, 1 % SDS, 50After 48   hours    cells  RIPA   buffer solution (50 mM Tris-HCl, 0.15 M NaCl, 1 mM EDTA, 1 % Tritons X-100, 

mM NaF, 1 mM Na3VO4, 5 mM dithiothreitol, 1 ㎍/㎖ leupeptin and 20 ㎍/㎖ PMSF, pH 7.4)을 이용하여 분해Decomposition of mM NaF, 1 mM Na3VO4, 5 mM dithiothreitol, 1 ㎍/㎖ leupeptin and 20 ㎍/㎖ PMSF, pH 7.4)  

하여 단백질을 얻었다. 25 ㎎의 단백질을 8 % SDS-polyacryamide gel electrophoresis를 이용하여 분리하였다.Thus, a protein was obtained. 25 mg of  protein was separated using  8 % SDS-polyacryamide gel electrophoresis.

단백질이 분리된 젤을 PVDF막에 전이시켰다. PVDF막을 anti-티로시나아제(1:500배 희석) 항체, α-tubulin 항체The protein-separated gel was transferred to the PVDF membrane. PVDF membrane  anti-tyrosinase(1:500 times  dilution) antibody, α-tubulin antibody

(1:10,000배 희석)로 배양한 후, horseradish peroxidase-conjugated anti-goat IgG 항체(1:10,000 dilutio(1:10,000 times   dilution)   after culture  ,  horseradish peroxidase-conjugated anti-goat IgG antibodies (1:10,000 dilutio

n)로 다시 배양하였다. 획득한 band를 immunobilon western reagent로 X-ray 필름에 노출시켜 결과를 확인하였It was cultured as n) again. The obtained  band was exposed to  immunobilon  western  reagent   on X-ray   film   confirmed

다.All.

Claims (3)

줄기세포 배양액 또는 그 배양액에서 분리된 단백질을 포함하는 미백용 화장료 조성물.
A cosmetic composition for whitening comprising a stem cell culture solution or a protein isolated from the culture solution.
제 1 항에 있어서, 줄기세포는 포유동물에서 유래된 성체줄기세포 또는 중간엽 줄기세포인 화장료 조성물.
The cosmetic composition according to claim 1, wherein the stem cells are adult stem cells or mesenchymal stem cells derived from mammals.
제 2 항에 있어서, 성체줄기세포는 지방조직, 골수조직 및 제대혈로 이루어진 군에서 선택된 하나 이상인 줄기 세포인 화장료 조성물.



The cosmetic composition of claim 2, wherein the adult stem cells are at least one stem cell selected from the group consisting of adipose tissue, bone marrow tissue, and cord blood.



KR1020190040779A 2019-04-08 2019-04-08 Inhibition of melanin synthesis using adult stem cells culture media KR20200118627A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190040779A KR20200118627A (en) 2019-04-08 2019-04-08 Inhibition of melanin synthesis using adult stem cells culture media

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190040779A KR20200118627A (en) 2019-04-08 2019-04-08 Inhibition of melanin synthesis using adult stem cells culture media

Publications (1)

Publication Number Publication Date
KR20200118627A true KR20200118627A (en) 2020-10-16

Family

ID=73035118

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190040779A KR20200118627A (en) 2019-04-08 2019-04-08 Inhibition of melanin synthesis using adult stem cells culture media

Country Status (1)

Country Link
KR (1) KR20200118627A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102326939B1 (en) * 2021-03-09 2021-11-17 주식회사 스마트셀랩 A cosmetic composition for skin whitening comprising co-culture medium of mesenchymal stem cell and immune cell

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102326939B1 (en) * 2021-03-09 2021-11-17 주식회사 스마트셀랩 A cosmetic composition for skin whitening comprising co-culture medium of mesenchymal stem cell and immune cell

Similar Documents

Publication Publication Date Title
KR100848056B1 (en) Inhibition of melanin synthesis using adult stem cells culture media
MISHIMA et al. Induction of melanogenesis suppression: cellular pharmacology and mode of differential action
KR101237430B1 (en) A cosmetic composition comprising stem cell culture medium and a process for producing the same
US9284528B2 (en) Use of stem cell conditioned medium to inhibit oxidation for anti-aging skin
KR20110054022A (en) Skin-whitening agent, anti-aging agent, and skin-care cosmetic agent
Ali et al. Biochemical aspects of mammalian melanocytes and the emerging role of melanocyte stem cells in dermatological therapies
KR20110054154A (en) Cosmetic composition containing immature fruit or seed extract of torreya nucifera
KR20200118627A (en) Inhibition of melanin synthesis using adult stem cells culture media
Kim et al. Anti-melanogenic activity of the novel herbal medicine, MA128, through inhibition of tyrosinase activity mediated by the p38 mitogen-activated protein kinases and protein kinase signaling pathway in B16F10 cells
CN110996902A (en) Anti-aging potential of extracellular metabolites isolated from bacillus coagulans MTCC5856
KR20110053051A (en) Preparation method of plant extract using high pressure-enzymatic decomposition technique and the cosmetic composition containing the extract
KR20120025244A (en) Cosmetic compositions for improving skin wrinkles comprising extract of camellia sasanqua
KR102178778B1 (en) Composition for anti-aging containing epidermal stem cell conditioned medium and use thereof
KR101808222B1 (en) Composition for improving skin elasticity containing sphallerocarpus gracilis extract
TWI789553B (en) Use of hemerocallis fulva linn. extract for manufacturing of a composition for promoting skeletal muscle basal metaboilc rate
TWI611815B (en) Use of stem cell conditioned medium to inhibit melanin formation for skin whitening
KR101146113B1 (en) Whitening cosmetic composition comprising embryonic stem cell-derived vascular angiogenic progenitor cells
TW202110468A (en) Use of rosa plant extract for anti-aging and anti-oxidation
US20180193248A1 (en) Determination of melanin inhibition potential of natural ingredients
KR102618453B1 (en) Composition for preventing or improving striae distensae comprising culture medium of cord blood stem cell
KR20180068914A (en) Composition for inhibition of aging comprising syringaresinol
Hong et al. Inhibition of melanogenesis by Erigeron canadensis via down-regulating melanogenic enzymes in B16F10 melanoma cells
WO2022240243A1 (en) Skin-whitening composition containing nanovesicles
TWI645861B (en) Extract of ganoderma formosanum mycelium for skin lightening and preparation method thereof
KR20100058858A (en) Anti-aging cosmetic composition containing glutamylamidoethyl indole